FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

385275000: Cutaneous AND/OR transdermal dosage form (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1479527018 Cutaneous AND/OR transdermal dosage form en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Cutaneous AND/OR transdermal dosage form Is a Type of drug preparation false Inferred relationship Some
    Cutaneous AND/OR transdermal dosage form Is a Dose form by site prepared for false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Mometasone furoate 1 mg/g cutaneous ointment Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Mometasone furoate 1 mg/g cutaneous lotion Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Fluticasone propionate 500 microgram/g cutaneous cream Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar+salicylic acid ointment BP Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar 10% paint Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar 7.5% paste BP Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Zinc+coal tar paste BP Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar ointment BPC Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Strong coal tar 40% solution Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar 10 mg/mL cutaneous lotion Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar 40% bath emulsion Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Strong coal tar solution+pine tar 5/5% gel Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar 10 mg/mL cutaneous cream Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar solution 10% cream Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Allantoin 20 mg/g and coal tar extract 50 mg/g cutaneous lotion Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely allantoin 20 milligram/1 gram and coal tar extract 50 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar 20% solution BP Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin ointment Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Dithranol+salicylic acid 0.25%/1.6% scalp gel Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Ichthammol 10% ointment BP Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Zinc+ichthammol cream BP Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Salicylic acid 2% ointment BP Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Zinc+salicylic acid paste BP Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Zinc+salicylic acid paste half strength Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous cream (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Calcipotriene 50micrograms/mL scalp solution Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely tacalcitol (as tacalcitol monohydrate) 4 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Tazarotene 0.05% aqueous gel Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Tazarotene 0.1% aqueous gel Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 0.1% ointment BP Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 0.2% ointment BP Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 0.5% ointment BP Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 1.5% ointment BP Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 0.2% paste BP Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 0.5% paste BP Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Dithranol 20 mg/g cutaneous cream Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely dithranol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 0.1% paste BP Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 1% paste BP Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Dithranol 2.5 mg/g cutaneous cream Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Dithranol 5 mg/g cutaneous cream Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Dithranol 10 mg/g cutaneous cream Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Dithranol 1 mg/g cutaneous cream Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 0.2% cream Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Anthralin 0.4% cream Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Benzalkonium 2.5 mg/g and polyethylene 219 mg/g cutaneous gel Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Aluminum oxide 52.2% paste Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Aluminium oxide 381 mg/g cutaneous paste Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Benzoyl peroxide 100 mg/g and potassium hydroxyquinoline sulfate 5 mg/g cutaneous cream Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Benzoyl peroxide+potassium hydroxyquinoline sulfate 5/0.5% lotio-gel Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Sulfur+salicylic acid cream BP Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Sulfur+salicylic acid ointment BPC Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely tetracycline hydrochloride 2.2 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Tretinoin 250 microgram/g cutaneous cream Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Tretinoin 100 microgram/g cutaneous gel Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Tretinoin 500 microgram/g cutaneous cream Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Tretinoin 250 microgram/g cutaneous lotion Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Clindamycin 1% roll-on lotion Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Clindamycin 1% topical alcoholic solution Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely salicylic acid 20 milligram/1 gram conventional release cutaneous solution (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely nicotinamide 40 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely adapalene 1 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely adapalene 1 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely benzoyl peroxide 40 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous lotion (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Benzoyl peroxide 50 mg/g cutaneous cream Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Benzoyl peroxide 100 mg/g cutaneous lotion Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely benzoyl peroxide 100 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Benzoyl peroxide 2.5% aqueous gel Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Benzoyl peroxide 5% aqueous gel Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Benzoyl peroxide 10% aqueous gel Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Benzoyl peroxide 10% wash Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Salicylic acid collodion BP 12% Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Lactic acid 250 mg/g and salicylic acid 250 mg/g cutaneous ointment Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Salicylic acid+boric acid in purified talc 3%/5% powder Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Salicylic acid+zinc oxide 5%/20% dusting powder Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Salicylic acid in white soft paraffin 60%/40% ointment Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Salicylic acid 17% liquid Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely salicylic acid 260 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Salicylic acid 110 mg/g cutaneous gel Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Salicylic acid+lactic acid 16.7%/16.7% paint Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely salicylic acid 500 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Bromine complexes Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Formaldehyde 36% lotion Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Formaldehyde 10% lotion Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Formaldehyde 15% lotion Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Formaldehyde lotion Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Podophyllin compound 15% paint BP Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely Podophyllum resin 200 milligram/1 gram and salicylic acid 250 milligram/1 gram conventional release cutaneous ointment (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Podophyllotoxin 5 mg/mL cutaneous solution Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Podophyllotoxin 1.5 mg/g cutaneous cream Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Dimethyl-ether propane aerosol Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Toughened silver nitrate BP 95% stick Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Aminobenzoic acid lotion Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Camouflaging preparations Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Product containing precisely povidone iodine 40 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some
    Coal tar extract 2% shampoo Has manufactured dose form False Cutaneous AND/OR transdermal dosage form Inferred relationship Some

    Start Previous Page 4 of 13 Next End

    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start